Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -42.865\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: COc1ccc(CCN(C)Cc2ccc(OCc3ccccc3)c(OC)c2)cc1OC
b: CCOC(=O)c1ccc(OS(=O)(=O)c2ccccc2)c(OC)c1
c: O=C(Oc1ccc2ccc(OC(=O)N3CCOCC3)cc2c1)N1CCOCC1
d: CCn1cc(C(=O)OCC(=O)Nc2c(C)n(C)n(-c3ccccc3)c2=O)c(=O)c2ccc(C)nc21
e: Cc1cc(NC(=O)Cn2c(=O)c3c(ncn3CC(C)C)n(Cc3ccccc3)c2=O)no1
Answer: a. COc1ccc(CCN(C)Cc2ccc(OCc3ccccc3)c(OC)c2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCN(C)Cc2ccc(OCc3ccccc3)c(OC)c2)cc1OC
COc1ccc(CCN(C)Cc2ccc(OCc3ccccc3)c(OC)c2)cc1OC
2-(3,4-dimethoxyphenyl)-N-[(3-methoxy-4-phenylmethoxyphenyl)methyl]-N-methylethanamine